trending Market Intelligence /marketintelligence/en/news-insights/trending/jYNxKNb5weXuKQgo3lvZvA2 content esgSubNav
In This List

Express Scripts closes $3.6B eviCore deal

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Express Scripts closes $3.6B eviCore deal

Express Scripts Holding Co. completed its $3.6 billion acquisition of privately held eviCore healthcare.

The company expects the deal to be accretive to adjusted EPS in 2018, excluding transaction-related expenses and amortization of intangibles.

Express Scripts' financial advisers on this transaction are Lazard Frères & Co. LLC and TripleTree LLC, and its legal advisers are Skadden Arps Slate Meagher & Flom LLP and Holland & Knight LLP.

EviCore's financial advisers for the deal are J.P. Morgan and Morgan Stanley, and its legal advisers are Paul Weiss Rifkind Wharton & Garrison LLP and Epstein Becker & Green PC.